{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:22:05Z","timestamp":1784809325722,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.crd.0000181621.84565.9d","type":"journal-article","created":{"date-parts":[[2005,10,17]],"date-time":"2005-10-17T09:48:20Z","timestamp":1129542500000},"page":"315-321","source":"Crossref","is-referenced-by-count":29,"title":["Tecadenoson"],"prefix":"10.1097","volume":"13","author":[{"given":"Carla","family":"Peterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Sanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population.","volume":"31","author":"Orejarena","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R2-9-20210203","article-title":"Heart Disease and Stroke Statistics\u20142005 Update.","year":"2005"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors.","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1568026033392246","article-title":"Pharmacology and therapeutic applications of A1 adenosine receptor ligands.","volume":"3","author":"Dhalla","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias).","volume":"108","author":"Blomstr\u00f6m-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"R6-9-20210203","first-page":"2479","article-title":"Management of common arrhythmias, part I: supraventricular arrhythmias.","volume":"65","author":"Hebbar","year":"2002","journal-title":"Am Fam Physician"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/01.CIR.99.8.1034","article-title":"Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.","volume":"99","author":"Glatter","year":"1999","journal-title":"Circulation"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-127-6-199709150-00001","article-title":"Adenosine-induced atrial arrhythmia: a prospective analysis.","volume":"127","author":"Strickberger","year":"1997","journal-title":"Ann Intern Med"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/med.2610120502","article-title":"Adenosine A1 and A2 receptors: structure\u2013function relationships.","volume":"12","author":"Van Galen","year":"1992","journal-title":"Med Res Rev"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","article-title":"Tissue distribution of adenosine receptor mRNAs in the rat.","volume":"118","author":"Dixon","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1527-3466.2003.tb00122.x","article-title":"CVT-510: a selective A1 adenosine receptor agonist.","volume":"21","author":"Cheung","year":"2003","journal-title":"Cardiovasc Drug Rev"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"C1233","DOI":"10.1152\/ajpcell.1996.271.4.C1233","article-title":"Electrophysiological and functional effects of adenosine on ventricular myocytes of various mammalian species.","volume":"271","author":"Song","year":"1996","journal-title":"Am J Physiol"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"2A","DOI":"10.1016\/S0002-9149(97)00256-7","article-title":"Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.","volume":"79","author":"Shryock","year":"1997","journal-title":"Am J Cardiol"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0022-3565(24)37317-3","article-title":"The A2A adenosine receptor mediates coronary vasodilation.","volume":"284","author":"Belardinelli","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjp.0703045","article-title":"A2A adenosine receptors in human peripheral blood cells.","volume":"129","author":"Gessi","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI118245","article-title":"Adenosine A2B receptors evoke interleukin-8 secretion in human mast cells: an enprofylline-sensitive mechanism with implications for asthma.","volume":"96","author":"Feoktistov","year":"1995","journal-title":"J Clin Invest"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0165-6147(00)89051-3","article-title":"Adenosine, antioxidant enzymes and cytoprotection.","volume":"16","author":"Ramkumar","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"16887","DOI":"10.1016\/S0021-9258(19)85277-8","article-title":"The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.","volume":"268","author":"Ramkumar","year":"1993","journal-title":"J Biol Chem"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bjp.0702287","article-title":"A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.","volume":"126","author":"Snowdy","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ddr.1143","article-title":"Negative chronotropic effect of CVT-510 in anesthetized and awake rats.","volume":"52","author":"Gao","year":"2001","journal-title":"Drug Dev Res"},{"key":"R21-9-20210203","first-page":"319","article-title":"Desensitization of G protein-coupled receptors.","volume":"51","author":"Freedman","year":"1996","journal-title":"Recent Prog Horm Res"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.RES.67.4.960","article-title":"Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction: mechanism and physiological implications.","volume":"67","author":"Froldi","year":"1990","journal-title":"Circ Res"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/107424840100600304","article-title":"Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.","volume":"6","author":"Lerman","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1009758501195","article-title":"Dose and rate-dependent effects of adenosine on atrial action potential duration in humans.","volume":"1","author":"Tebbenjohanns","year":"1997","journal-title":"J Interv Card Electrophysiol"},{"key":"R25-9-20210203","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/cvr\/28.9.1385","article-title":"Effects of adenosine on atrial refractoriness and arrhythmias.","volume":"28","author":"Kabell","year":"1994","journal-title":"Cardiovasc Res"},{"key":"R26-9-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system.","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"R27-9-20210203","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0735-1097(03)00987-2","article-title":"Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.","volume":"42","author":"Prystowsky","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R28-9-20210203","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/CIRCULATIONAHA.104.510982","article-title":"Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.","volume":"111","author":"Ellenbogen","year":"2005","journal-title":"Circulation"},{"key":"R29-9-20210203","doi-asserted-by":"crossref","first-page":"L1012","DOI":"10.1152\/ajplung.00353.2002","article-title":"Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model.","volume":"284","author":"Fan","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R30-9-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0165-6147(03)00193-7","article-title":"Research applications and implications of adenosine in diseased airways.","volume":"24","author":"Spicuzza","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"R31-9-20210203","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0196-0644(05)82650-2","article-title":"Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia.","volume":"21","author":"McCabe","year":"1992","journal-title":"Ann Emerg Med"},{"key":"R32-9-20210203","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0196-0644(05)80829-7","article-title":"Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia.","volume":"20","author":"Cairns","year":"1991","journal-title":"Ann Emerg Med"},{"key":"R33-9-20210203","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0196-0644(94)70128-8","article-title":"Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.","volume":"24","author":"Gausche","year":"1994","journal-title":"Ann Emerg Med"},{"key":"R34-9-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose-ranging and comparison with verapamil: assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.","volume":"113","author":"DiMarco","year":"1990","journal-title":"Ann Intern Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006534-200511000-00047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T23:56:05Z","timestamp":1736034965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-200511000-00009"}},"subtitle":["A Novel, Selective A1 Adenosine Receptor Agonist"],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000181621.84565.9d","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}